Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results

被引：2
|
作者：
Park, Silvia [1 ]
Park, Sung-Soo [1 ]
Cho, Byoung Sik [2 ]
Lim, Sungwon [3 ,4 ]
Kim, Kwan Hyun [4 ]
Choi, Gyucheol [4 ]
Ham, Seunghyeok [4 ]
Lee, Seongjoon [4 ]
Park, Sesun [4 ]
Lee, Gunjae [5 ]
Lee, Junyoung [6 ]
Song, Edward [7 ]
Koo, Jamin [3 ,5 ]
Kim, Heeje [2 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Catholic Hematol Hosp, Dept Hematol,Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Coll Med, Seoul, South Korea
[3] ImpriMed Inc, Mountain View, CA USA
[4] ImpriMedKorea Inc, Seoul, South Korea
[5] Hongik Univ, Dept Chem Engn, Seoul, South Korea
[6] Korea Adv Inst Sci & Technol, Dept Comp Sci, Seoul, South Korea
[7] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PATIENT-DERIVED CELLS FOR EX VIVO DRUG SCREENING STUDIES OF GLIOMAS
    El-Heliebi, Amin
    Urbanic-Purkart, Tadeja
    Mahdy-Ali, Kariem
    Skofler, Christina
    Gerlitz, Lisa
    Stanzer, Stefanie
    Franz, Joakim
    Harbusch, Nora
    Madl, Tobias
    Widhalm, Georg
    Rossler, Karl
    Tomberger, Martina
    Mattersdorfer, Karin
    Kroneis, Thomas
    Oberhuber, Monika
    Pieber, Thomas
    Prietl, Barbara
    NEURO-ONCOLOGY, 2022, 24 : 209 - 209
  • [2] Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients
    Morrison, Gladys
    Lenkala, Divya
    LaCroix, Bonnie
    Ziliak, Dana
    Abramson, Vandana
    Morrow, Phuong Khanh
    Forero, Andres
    Van Poznak, Catherine
    Rugo, Hope S.
    Nanda, Rita
    O'Donnell, Peter H.
    Huang, R. Stephanie
    ONCOTARGET, 2016, 7 (25) : 38359 - 38366
  • [3] Patient-derived ex vivo models to test drug responses of disseminated cancer cells in various metastatic niches
    Wohrl, Lukas
    Botteron, Catherine
    Weidele, Kathrin
    Treitschke, Steffi
    Das, Durdam
    Werner-Klein, Melanie
    Hoffmann, Martin
    Guzvic, Natasa Stojanovic
    Materna-Reichelt, Silvia
    Weber, Florian
    Engelmann, Simon
    Mayr, Roman
    Guzvic, Miodrag
    Haferkamp, Sebastian
    Seitz, Stephan
    Klein, Christoph A.
    Werno, Christian
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Predictive Drug Sensitivity Testing with Patient-Derived Cultured Leukemia Cells
    Ancheta, Richard Gopez
    Burian, Carol
    Miller, William E.
    Finlay, Darren
    Vuori, Kristiina
    Paternostro, Giovanni
    Mason, James
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S196 - S197
  • [5] In silico modeling predicts drug sensitivity of patient-derived cancer cells
    Sandeep C Pingle
    Zeba Sultana
    Sandra Pastorino
    Pengfei Jiang
    Rajesh Mukthavaram
    Ying Chao
    Ila Sri Bharati
    Natsuko Nomura
    Milan Makale
    Taher Abbasi
    Shweta Kapoor
    Ansu Kumar
    Shahabuddin Usmani
    Ashish Agrawal
    Shireen Vali
    Santosh Kesari
    Journal of Translational Medicine, 12
  • [6] In silico modeling predicts drug sensitivity of patient-derived cancer cells
    Pingle, Sandeep C.
    Sultana, Zeba
    Pastorino, Sandra
    Jiang, Pengfei
    Mukthavaram, Rajesh
    Chao, Ying
    Bharati, Ila Sri
    Nomura, Natsuko
    Makale, Milan
    Abbasi, Taher
    Kapoor, Shweta
    Kumar, Ansu
    Usmani, Shahabuddin
    Agrawal, Ashish
    Vali, Shireen
    Kesari, Santosh
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [7] Ex vivo drug sensitivity assay with a panel of cancer patient-derived spheroids of small cell neuroendocrine carcinoma of uterine cervix
    Tanaka, Mie
    Kubota, Satoshi
    Ito, Yu
    Kiyohara, Yumiko
    Endo, Hiroko
    Kondo, Jumpei
    Nakagawa, Satoshi
    Okazawa, Akiko
    Matsuzaki, Shinya
    Kimura, Toshihiro
    Kobayashi, Eiji
    Ueda, Yutaka
    Yoshino, Kiyoshi
    Kamiura, Shoji
    Kimura, Tadashi
    Inoue, Masahiro
    CANCER RESEARCH, 2019, 79 (13)
  • [8] A robust method for expanding patient-derived circulating tumor cells ex vivo.
    Xiao, Jerry
    Kassner, Joshua D.
    Stanton, Kelly
    Schlegel, Richard
    Pohlmann, Paula R.
    Agarwal, Seema
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Biomimetic Culture Platform for Ex Vivo Preservation of Patient-Derived Multiple Myeloma Cells
    Zilberberg, Jenny
    Zhang, Wenting
    Siegel, David S.
    Lee, Woo Y.
    CANCER RESEARCH, 2017, 77
  • [10] Establishment of a patient-derived acute myeloid leukemia (AML) ex vivo platform for evaluation of novel therapeutic agents
    Verma, Bhavna
    Tati, Swetha
    Ruggeri, Bruce
    Wesa, Amy
    CANCER RESEARCH, 2019, 79 (13)
12345